ASCO Guideline: Management of dyspnea in advanced cancer
Management of Dyspnea in Advanced Cancer: ASCO Guideline – Journal of Clinical Oncology Commentary on Twitter (thread – click for more) 1/ How can we better manage dyspnea in people with advanced cancer? Wonderful to see this new @ASCO Guideline out. Led by Drs. @DrDavidHui and @campbell_meg #supponc #pallonc Full text: https://t.co/qbdhzbibKw pic.twitter.com/f2Qf6GswvK — […]
The post ASCO Guideline: Management of dyspnea in advanced cancer appeared first on Links Medicus.
Study: Patients with severe COVID-19 might shed viable virus during prolonged periods of up to 4 weeks
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19 – Clinical Microbiology and Infection Commentary on Twitter Different pattern of SARS-CoV-2 viability in mild cases (viral replication max 10 days) vs severe COVID-19: viable virus demonstrated up to 4 weeks even in the presence of high levels of neutralizing activityhttps://t.co/dhERkipKJ0 […]
The post Study: Patients with severe COVID-19 might shed viable virus during prolonged periods of up to 4 weeks appeared first on Links Medicus.
M-A: Asthma does not increase the risk of infection, hospitalization, ICU admission, and mortality from COVID-19
Asthma and risk of infection, hospitalisation, ICU admission and mortality from COVID-19: Systematic review and meta-analysis – Journal of Asthma Commentary: Study: Asthma does not increase risk of severe illness or death from COVID-19 – News Medical See also: COVID vaccine and asthma: why most sufferers won’t be prioritised in the next phase of rollout – […]
The post M-A: Asthma does not increase the risk of infection, hospitalization, ICU admission, and mortality from COVID-19 appeared first on Links Medicus.
Editorial: Prophylactic anticoagulation for patients in hospital with covid-19
Prophylactic anticoagulation for patients in hospital with covid-19 – The BMJ Related: Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials AND Cohort study: Early initiation of prophylactic anticoagulation linked to reduced mortality in patients admitted to hospital with Covid-19
The post Editorial: Prophylactic anticoagulation for patients in hospital with covid-19 appeared first on Links Medicus.
FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias
FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias – STAT FDA Safety Alert: Pulse Oximeter Accuracy and Limitations: FDA Safety Communication – U.S. Food & Drug Administration Related: “Racial Bias in Pulse Oximetry Measurement”. In two large cohorts, Black patients had nearly three times the frequency of occult hypoxemia […]
The post FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias appeared first on Links Medicus.
FDA: No credible evidence of food or food packaging associated with viral transmission of SARS-CoV-2
COVID-19 Update: USDA, FDA Underscore Current Epidemiologic and Scientific Information Indicating No Transmission of COVID-19 Through Food or Food Packaging – U.S. Food & Drug Administration Commentary: FDA: COVID-19 Not Transmitted by Food or Packaging – WebMD
The post FDA: No credible evidence of food or food packaging associated with viral transmission of SARS-CoV-2 appeared first on Links Medicus.
The effects of tobacco control policies on global smoking prevalence
The effects of tobacco control policies on global smoking prevalence – Nature Medicine Commentaries on Twitter Analysis of global #smoking prevalence trends from 2009-2017 demonstrates the effectiveness of #tobacco control policies across countries, and highlights gaps that remain for achieving universal adoption of anti-tobacco interventions. https://t.co/g86jhDUVFu #publichealth pic.twitter.com/fQZS4KKJIF — Nature Medicine (@NatureMedicine) January 25, […]
The post The effects of tobacco control policies on global smoking prevalence appeared first on Links Medicus.
WHO announces updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance
News release: WHO announces updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance – World Health Organization Publication: Update on the use of nucleic acid amplification tests to detect TB and drug-resistant TB: rapid communication – World Health Organization
The post WHO announces updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance appeared first on Links Medicus.
Long Covid: Sequelae in adults at 6 Months after COVID-19 infection
Sequelae in Adults at 6 Months After COVID-19 Infection – JAMA Network Open Commentaries: Almost a third of people with ‘mild’ COVID-19 still battle symptoms months later, study finds – CNN AND Nearly One Third of Covid-19 Survivors Have Symptoms, Some Up To 9 Months Later, New Study Finds – Forbes Commentary on Twitter […]
The post Long Covid: Sequelae in adults at 6 Months after COVID-19 infection appeared first on Links Medicus.
Intensive care management of patients with COVID-19: a practical approach
Intensive care management of patients with COVID-19: a practical approach – Intensive Care Management Related Guideline: Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update AND Infographic
The post Intensive care management of patients with COVID-19: a practical approach appeared first on Links Medicus.